Exploring the experience of the physicians regarding COVID-19, its complications and management

Maimunah Sobhi Altayasinah; Lin Mosbah Katramiz; Munira Abdelrahim Alahmed; Doaa Kamal AlKhalidi; Shazia Qasim Jamshed

doi:10.5455/njppp.2023.13.11549202209012022

2023, Vol: 13, Issue: 3

13/3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2023; 13(2): 409-418

doi: 10.5455/njppp.2023.13.11549202209012022

Exploring the experience of the physicians regarding COVID-19, its complications and management

Maimunah Sobhi Altayasinah, Lin Mosbah Katramiz, Munira Abdelrahim Alahmed, Doaa Kamal AlKhalidi, Shazia Qasim Jamshed.

Abstract
Background: COVID-19 infection is a disease that remains the main concern globally due to high admissions and fatality rates among patients. Clinical manifestation and choice of treatment are various. Therefore, this study was developed to explore the physicians’ perceptions in this regard in a semi-governmental hospital in Sharjah.

Aims and Objectives: The objective of this research is to (1) to outline physicians’ descriptions of the clinical presentation of COVID-19, (2) to explore the physicians’ perceptions regarding the different aspects of COVID-19 and its complications, and (3) explore the physicians’ experiences regarding the treatment of COVID-19 cases.

Materials and Methods: A descriptive qualitative design was approached. A semi-structured interview guide was developed, validated and used for data collection. Ten in-depth individual interviews with physicians were conducted. Interviews were recorded, transcribed, and thematically analyzed.

Results: After analysis, three main themes with their sub-themes emerged to describe physicians’ experience regarding COVID-19’s clinical presentation, complications, and management. Sub-themes cleared-up COVID-19’s signs, symptoms, and risk factors along with admission’s requirements. Furthermore, it showed COVID-19’s complication in main organs. Moreover, COVID-19’s treatment was clarified for both home-quarantine and admitted patients along with instructions for discharged patients.

Conclusion: Cases varied in severity and classified from asymptomatic to severe. It showed the requirements for hospitalization and risk factors associated with severity. The management of COVID-19 disease followed by MOHAP protocol and provided adequate outcomes from physicians. Vaccination was one of physicians’ recommendations.

Key words: COVID-19; Complications; COVID-19 Pneumonia; Coronavirus CVDs; Post-COVID; Qualitative

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Maimunah Sobhi Altayasinah Articles by Lin Mosbah Katramiz Articles by Munira Abdelrahim Alahmed Articles by Doaa Kamal AlKhalidi Articles by Shazia Qasim Jamshed
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Altayasinah MS, Katramiz LM, Alahmed MA, AlKhalidi DK, Jamshed SQ. Exploring the experience of the physicians regarding COVID-19, its complications and management. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 409-418. doi:10.5455/njppp.2023.13.11549202209012022

Web Style

Altayasinah MS, Katramiz LM, Alahmed MA, AlKhalidi DK, Jamshed SQ. Exploring the experience of the physicians regarding COVID-19, its complications and management. https://www.njppp.com/?mno=130372 [Access: March 02, 2023]. doi:10.5455/njppp.2023.13.11549202209012022

AMA (American Medical Association) Style

Altayasinah MS, Katramiz LM, Alahmed MA, AlKhalidi DK, Jamshed SQ. Exploring the experience of the physicians regarding COVID-19, its complications and management. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 409-418. doi:10.5455/njppp.2023.13.11549202209012022

Vancouver/ICMJE Style

Altayasinah MS, Katramiz LM, Alahmed MA, AlKhalidi DK, Jamshed SQ. Exploring the experience of the physicians regarding COVID-19, its complications and management. Natl J Physiol Pharm Pharmacol. (2023), [cited March 02, 2023]; 13(2): 409-418. doi:10.5455/njppp.2023.13.11549202209012022

Harvard Style

Altayasinah, M. S., Katramiz, . L. M., Alahmed, . M. A., AlKhalidi, . D. K. & Jamshed, . S. Q. (2023) Exploring the experience of the physicians regarding COVID-19, its complications and management. Natl J Physiol Pharm Pharmacol, 13 (2), 409-418. doi:10.5455/njppp.2023.13.11549202209012022

Turabian Style

Altayasinah, Maimunah Sobhi, Lin Mosbah Katramiz, Munira Abdelrahim Alahmed, Doaa Kamal AlKhalidi, and Shazia Qasim Jamshed. 2023. Exploring the experience of the physicians regarding COVID-19, its complications and management. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 409-418. doi:10.5455/njppp.2023.13.11549202209012022

Chicago Style

Altayasinah, Maimunah Sobhi, Lin Mosbah Katramiz, Munira Abdelrahim Alahmed, Doaa Kamal AlKhalidi, and Shazia Qasim Jamshed. "Exploring the experience of the physicians regarding COVID-19, its complications and management." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 409-418. doi:10.5455/njppp.2023.13.11549202209012022

MLA (The Modern Language Association) Style

Altayasinah, Maimunah Sobhi, Lin Mosbah Katramiz, Munira Abdelrahim Alahmed, Doaa Kamal AlKhalidi, and Shazia Qasim Jamshed. "Exploring the experience of the physicians regarding COVID-19, its complications and management." National Journal of Physiology, Pharmacy and Pharmacology 13.2 (2023), 409-418. Print. doi:10.5455/njppp.2023.13.11549202209012022

APA (American Psychological Association) Style

Altayasinah, M. S., Katramiz, . L. M., Alahmed, . M. A., AlKhalidi, . D. K. & Jamshed, . S. Q. (2023) Exploring the experience of the physicians regarding COVID-19, its complications and management. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 409-418. doi:10.5455/njppp.2023.13.11549202209012022

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information



Copyright © 2023 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article